Ori Biotech focuses on advancing cell and gene therapies through its innovative platform designed to streamline the manufacturing process. The company employs a proprietary technology that enhances the efficiency and scalability of cell therapy production, enabling the rapid and cost-effective generation of high-quality therapeutic cells. This platform integrates automation and real-time monitoring, which not only improves consistency but also reduces the risk of contamination during the manufacturing process.

In addition to its manufacturing capabilities, Ori Biotech is committed to addressing the challenges associated with the commercialization of cell and gene therapies. The company’s technology is designed to support a wide range of applications, from research and development to large-scale production, ensuring that therapies can be delivered to patients more effectively. By focusing on both the scientific and operational aspects of cell therapy, Ori Biotech aims to accelerate the availability of transformative treatments for various diseases.

United Kingdom

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments.

By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.

So complex manufacturing challenges can be put where they belong – in the past.

Ori Biotech

Company Details